IBEX Technologies Inc.
IBXNFOTCHealthcare
$1.00
$-0.07(-6.54%)
Market Cap$25270800
P/E Ratio—
52W High$1.1
52W Low$0.56
IBEX Technologies Inc. (IBXNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IBXNF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2024Report Date: Mar 18, 2024EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q1 FY2024
FY ends December
Report Date
Mar 18, 2024
After Market Close
IBXNF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2024 | Mar 18, 2024 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 14, 2023 | — | $0.02 | — | $0.00B | — | — |
| — Q4 FY2023 | Nov 9, 2023 | — | $0.07 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 7, 2023 | — | $0.03 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 20, 2023 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 8, 2022 | — | $0.02 | — | $0.00B | — | — |
| — Q4 FY2022 | Nov 10, 2022 | — | $0.00 | — | $0.00B | — | — |
| — Q2 FY2022 | Jun 10, 2022 | — | $0.02 | — | $0.00B | — | — |
Q1 FY2024
Mar 18, 2024
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 14, 2023
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Nov 9, 2023
EPS Actual
$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 7, 2023
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 20, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 8, 2022
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Nov 10, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2022
Jun 10, 2022
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for IBXNF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2024 | Mar 18, 2024 | — | $1.07 | — | — |
| — Q4 FY2023 | Dec 14, 2023 | — | $0.67 | $0.67 | +0.00% |
| — Q4 FY2023 | Nov 9, 2023 | — | $0.70 | $0.70 | +0.00% |
| — Q2 FY2023 | Jun 7, 2023 | — | $0.56 | $0.56 | +0.00% |
| — Q1 FY2023 | Mar 20, 2023 | — | $0.58 | $0.58 | +0.00% |
| — Q4 FY2022 | Dec 8, 2022 | — | $0.43 | $0.43 | +0.00% |
| — Q4 FY2022 | Nov 10, 2022 | — | $0.43 | $0.43 | +0.80% |
| — Q2 FY2022 | Jun 10, 2022 | — | $0.43 | $0.43 | +0.00% |
Q1 FY2024—
Report Date
Mar 18, 2024
EPS Beat/Miss
—
Price Before
$1.07
Price After
—
Q4 FY2023+0.00%
Report Date
Dec 14, 2023
EPS Beat/Miss
—
Price Before
$0.67
Price After
$0.67
Q4 FY2023+0.00%
Report Date
Nov 9, 2023
EPS Beat/Miss
—
Price Before
$0.70
Price After
$0.70
Q2 FY2023+0.00%
Report Date
Jun 7, 2023
EPS Beat/Miss
—
Price Before
$0.56
Price After
$0.56
Q1 FY2023+0.00%
Report Date
Mar 20, 2023
EPS Beat/Miss
—
Price Before
$0.58
Price After
$0.58
Q4 FY2022+0.00%
Report Date
Dec 8, 2022
EPS Beat/Miss
—
Price Before
$0.43
Price After
$0.43
Q4 FY2022+0.80%
Report Date
Nov 10, 2022
EPS Beat/Miss
—
Price Before
$0.43
Price After
$0.43
Q2 FY2022+0.00%
Report Date
Jun 10, 2022
EPS Beat/Miss
—
Price Before
$0.43
Price After
$0.43
Beat Rate0 / 8 quarters
Largest Move+0.80% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IBXNF ends December
IBEX Technologies Inc. (IBXNF) most recently reported earnings on March 18, 2024 for Q1 FY2024, posting EPS of $0.00 (in line with the analyst consensus of —). The next IBXNF earnings date is expected around September 1, 2026.
Each quarter, investors track IBXNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IBXNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IBXNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IBXNF earnings · 4 questionsIBEX Technologies Inc.'s next earnings report is expected around September 1, 2026. IBXNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IBXNF historically reports after market close (AMC).
IBXNF earnings datewhen is IBXNF earningsIBXNF next earnings datewhen does IBXNF report earningsIBXNF earnings calendar
▸ Source: FMP · IBEX Technologies Inc. SEC filings · US GAAP · IBEX Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026